Results 91 to 100 of about 25,773 (228)

A Pan‐Hepatic T‐Cell Atlas Identifies Disease‐Specific Immune Dysfunction and Therapeutic Targets for Immunotherapy

open access: yesMedComm, Volume 7, Issue 11, November 2026.
A Pan‐HEpatic single‐cell Atlas of T cells (Pheat) was constructed covering chronic hepatitis, cirrhosis, hepatocellular carcinoma (HCC), and healthy controls. CD8+ exhausted T cells (Tex) and CD4+ regulatory T cells (Treg) were delineated profound through decoding molecular and cellular variance, immune checkpoint networks, pathway analysis, and drug ...
Si‐Yuan Chen   +18 more
wiley   +1 more source

Chronic HBV patients divided into three groups based on HBV DNA and HBeAg levels.

open access: yes, 2014
HBeAg levels, HBsAg levels and HBV DNA were measured in 45 chronic HBV patients. (A) HBV patients were divided into an HBeAgnegative/HBeAglow group (100 IU/ml).
Zwier M. Groothuismink (563332)   +5 more
core   +1 more source

HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis.

open access: yesPLoS ONE, 2017
BackgroundHBeAg seroconversion is an important intermediate outcome in HBeAg-positive chronic hepatitis B (CHB) patients. This study aimed to compare the effect of nucleos(t)ide analogs (NAs) on HBeAg seroconversion in treating CHB with lamivudine ...
Tongjing Xing   +3 more
doaj   +1 more source

HLA‐A*11:01 Identifies Patients at Risk for Persistent Viraemia and Advanced Fibrosis in HDV Infection

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 10, Page 1432-1447, November 2026.
The HLA‐A*11:01 allele is associated with persistent viraemia and advanced liver fibrosis in HDV infection. HLA‐A*11:01 carriers exhibit a reduced T‐cell repertoire, suggesting a narrower T‐cell response to the infection. ABSTRACT Background Hepatitis delta virus (HDV) infection causes the most severe form of viral hepatitis, with highly heterogeneous ...
Maria Francesca Cortese   +11 more
wiley   +1 more source

Markov model schematic with entry points active HBeAg-positive, active HBeAg-negative disease, and cirrhosis, and transition between states according to annual transition estimates.

open access: yes, 2015
Markov model schematic with entry points active HBeAg-positive, active HBeAg-negative disease, and cirrhosis, and transition between states according to annual transition estimates.
Samuel K. So (229078)   +2 more
core   +1 more source

Peripheral and intrahepatic B-cell subsets contribute to HBeAg seroconversion in patients with chronic hepatitis B

open access: yesVirology Journal
The immunopathogenesis of chronic hepatitis B (CHB) with unclear immune phases hinders functional cure. For highly infectious HBeAg-positive (HBeAg+) patients where functional cure is unattainable, achieving sustained HBeAg seroconversion constitutes the
Jing Zuo   +6 more
doaj   +1 more source

Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA

open access: yesViruses
Full-length hepatitis B virus (HBV) transcripts of chimpanzees and patients treated with multidose (MD) HBV siRNA ARC-520 and entecavir (ETV) were characterized by single-molecule real-time (SMRT) sequencing, identifying multiple types of transcripts ...
Christine I. Wooddell   +7 more
doaj   +1 more source

Proteomic Analysis of Serum Extracellular Vesicles Revealed Fibulin‐3 as a Novel Predictive Biomarker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B

open access: yesHepatology Research, Volume 56, Issue 11, Page 1614-1631, November 2026.
We carried out proteomic analysis of serum extracellular vesicles to identify biomarkers predictive of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B receiving nucleos(t)ide analog therapy. Candidate proteins identified through proteomic analysis were subsequently quantified in serum by ELISA.
Emi Sometani   +21 more
wiley   +1 more source

Cumulative rate of SRR achievement in patients with ETV therapy by HBeAg status at baseline.

open access: yes, 2016
SRR (sustained response rate) was defined as HBV DNA
Paweł Rajewski (3185898)   +6 more
core   +1 more source

Higher risk of postpartum phase transition to immune-active among HBeAg-positive pregnant women with indeterminate phase

open access: yesFrontiers in Cellular and Infection Microbiology
BackgroundUnderstanding the natural history of hepatitis B virus (HBV) infection helps determine the optimal timing of antiviral therapy. However, a gap exists in the literature regarding the dynamics of the natural history of HBV infection in pregnant ...
Qiao Tang   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy